These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 324036)
21. Influence of aspirin in the management of asymptomatic carotid artery stenosis. VA Cooperative Study Group on Asymptomatic Carotid Stenosis. Hobson RW; Krupski WC; Weiss DG J Vasc Surg; 1993 Feb; 17(2):257-63; discussion 263-5. PubMed ID: 8433421 [TBL] [Abstract][Full Text] [Related]
22. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease. Friedman LM Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355 [TBL] [Abstract][Full Text] [Related]
23. High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. Stroke; 1987; 18(2):325-34. PubMed ID: 2882626 [TBL] [Abstract][Full Text] [Related]
24. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Moore WS; Barnett HJ; Beebe HG; Bernstein EF; Brener BJ; Brott T; Caplan LR; Day A; Goldstone J; Hobson RW Stroke; 1995 Jan; 26(1):188-201. PubMed ID: 7839390 [TBL] [Abstract][Full Text] [Related]
25. Aspirin for prevention of stroke: a review. Fields WS Am J Med; 1983 Jun; 74(6A):61-5. PubMed ID: 6344627 [TBL] [Abstract][Full Text] [Related]
26. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. Farrell B; Godwin J; Richards S; Warlow C J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1044-54. PubMed ID: 1783914 [TBL] [Abstract][Full Text] [Related]
27. [Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole]. Bousser MG; Eschwège E; Haguenau M; Lefauconnier JM; Thibult N; Touboul D; Touboul PJ Presse Med; 1983 Dec; 12(48):3049-57. PubMed ID: 6228913 [TBL] [Abstract][Full Text] [Related]
28. Platelet aggregation in focal cerebral ischemia -a clinical study. Hansen PE; Hansen JH; Stenbjerg S Acta Neurol Scand; 1982 Mar; 65(3):212-8. PubMed ID: 7080806 [TBL] [Abstract][Full Text] [Related]
29. Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Koudstaal PJ; Algra A; Pop GA; Kappelle LJ; van Latum JC; van Gijn J Lancet; 1992 Sep; 340(8820):630-3. PubMed ID: 1355211 [TBL] [Abstract][Full Text] [Related]
30. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
31. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM; Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653 [TBL] [Abstract][Full Text] [Related]
32. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS; Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070 [TBL] [Abstract][Full Text] [Related]
33. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD; Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527 [TBL] [Abstract][Full Text] [Related]
34. Amaurosis fugax: prognosis and the role of acetylsalicylic acid. Gans M; Anderson D Can J Ophthalmol; 1994 Jun; 29(3):115-8. PubMed ID: 7922849 [TBL] [Abstract][Full Text] [Related]
35. Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Olsson JE; Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson O; Tornberg A Stroke; 1980; 11(1):4-9. PubMed ID: 7355429 [TBL] [Abstract][Full Text] [Related]
36. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing. Komiya T; Kudo M; Urabe T; Mizuno Y Stroke; 1994 Dec; 25(12):2337-42. PubMed ID: 7974570 [TBL] [Abstract][Full Text] [Related]
37. Aspirin: dose and indications in modern stroke prevention. van Gijn J Neurol Clin; 1992 Feb; 10(1):193-207; discussion 208. PubMed ID: 1532629 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study. Bellavance A Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945 [TBL] [Abstract][Full Text] [Related]
39. Does platelet antiaggregant therapy lessen the severity of stroke? Grotta JC; Lemak NA; Gary H; Fields WS; Vital D Neurology; 1985 May; 35(5):632-6. PubMed ID: 3887210 [TBL] [Abstract][Full Text] [Related]
40. Persantine aspirin trial in cerebral ischemia--Part III: Risk factors for stroke. The American-Canadian Co-Operative Study Group. Stroke; 1986; 17(1):12-8. PubMed ID: 2868549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]